Probiotics (Lactobacillus gasseri)
gut_healthAlso known as: L. gasseri SBT2055, L. gasseri BNR17, Lactobacillus gasseri
About
A strain-specific probiotic with the most consistent clinical evidence among probiotic strains for supporting healthy visceral fat levels. A well-designed 12-week RCT using abdominal CT imaging demonstrated L. gasseri SBT2055 may support healthy body weight and abdominal fat distribution.
How It Works
Strain-specific probiotic that modulates the gut-brain-adipose axis. L. gasseri SBT2055 reduces dietary fat absorption by increasing fecal fat excretion (by ~8-18%), reduces pro-inflammatory cytokine production in visceral adipose tissue, and modulates bile acid metabolism. Also influences leptin and ghrelin signaling through short-chain fatty acid (SCFA) production and vagal nerve pathways.
Evidence For Conditions
| Condition | Grade | Studies | Participants | |
|---|---|---|---|---|
| Abdominal Fat Reduction | A | 5 | 400 | View → |
| Obesity | C | 15 | 1500 | View → |
Side Effects
- Bloating (initial colonization)
- Gas
- GI discomfort (transient)
Drug & Supplement Interactions
- Immunosuppressants (probiotics may stimulate immune system)
- Antibiotics (may reduce probiotic effectiveness)
Always inform your healthcare provider about all supplements you take.
Related Ingredients
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.